Project to increase availability of malaria drug has worked, study finds

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7451 (Published 2 November 2012)
Cite this as: BMJ 2012;345:e7451

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anne Gulland
  1. 1London

An evaluation of a controversial initiative to broaden access to malaria medicines has found that in pilot studies it rapidly increased the availability and lowered the price of the drugs.1

A paper in the Lancet looks at the Affordable Medicines Facility malaria (AMFm), an initiative launched by the Global Fund to fight Aids, Tuberculosis and Malaria in 2010 to increase uptake of quality assured artemisinin based combination therapies (QAACTs). The facility was introduced because of concerns that uptake of these treatments, the most effective way to treat malaria, was too low because of their high cost and poor availability. There was also concern about the emergence of artemisinin resistance, exacerbated by use of monotherapies.

The fund negotiated a …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL